Skip to main content

GDTC

CytoMed Therapeutics Ltd

Company with tickers: GDTC

CIK
1873093
CUSIP
Y1R80M106
Shares Outstanding
11,832,835
13F Activity (30d)
2 filings 2 filers

Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.

Holders: 3
Total Value: $16,339
Total Shares: 16,339

Institutional Ownership Trend

12 quarters

Holder Concentration

Across 3 13F filers · Δ vs Dec 31, 2025
Top Holder
62.0%
Jun 2023 → Mar 2026 · range 0.0% – 100.0%
+5.9 pts
Top 5
100.0%
Jun 2023 → Mar 2026 · range 0.0% – 100.0%
0.0 pts
Top 10
100.0%
Jun 2023 → Mar 2026 · range 0.0% – 100.0%
0.0 pts
HHI
5,280
Jun 2023 → Mar 2026 · range 0 – 10,000
Highly concentrated +1,246

Quarterly Activity

vs Dec 31, 2025
New
1
Increased
1
Decreased
0
Sold Out
3
Unchanged
1
Holder count: -2
Institutional value: -77.0%
Shares held: -69.2%

Top Buyers

vs Dec 31, 2025
Institution Added Now Holds Open

Top Sellers

vs Dec 31, 2025
No qualifying movers this quarter.

Top New Positions

vs Dec 31, 2025
Institution Acquired Value (USD) Open

Top Sold-Out Positions

vs Dec 31, 2025
Institution Previously Held Last Value (USD) Open
Showing 3 of 3
Export CSV
Holder Value (USD) % of 13F Shares Open